Business Standard

Page 10 - Pharma Sector

Glenmark Pharma gets USFDA nod for drug to treat multiple sclerosis

The capsules are used in the treatment of adult patients with relapsing forms of multiple sclerosis

Glenmark Pharma gets USFDA nod for drug to treat multiple sclerosis
Updated On : 19 Jun 2020 | 12:31 PM IST

AstraZeneca Covid-19 vaccine to be shared across Europe, says France

The Netherlands also made clear on Monday that the vaccines would be available to all EU countries that sign up to the scheme after Belgium criticised the deal

AstraZeneca Covid-19 vaccine to be shared across Europe, says France
Updated On : 15 Jun 2020 | 9:10 PM IST

With little access to doctors, drug firms go digital to stay relevant

The rise of e-pharmacies and tele-consultations during Covid-19 has made it easier for healthcare companies to access patient pools

With little access to doctors, drug firms go digital to stay relevant
Updated On : 13 Jun 2020 | 11:40 PM IST

Dr Reddy's inks pact with Gilead to manufacture, market Remdesivir in India

Dr Reddy's would need to scale up manufacturing and obtain regulatory approval for marketing of this drug in respective countries, the company said

Dr Reddy's inks pact with Gilead to manufacture, market Remdesivir in India
Updated On : 13 Jun 2020 | 3:48 PM IST

AstraZeneca, Gilead merger likely to hit political, strategic hurdles

Political opposition from both the UK and the US could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak, Citigroup said

AstraZeneca, Gilead merger likely to hit political, strategic hurdles
Updated On : 08 Jun 2020 | 9:41 PM IST

Hyderabad's Raghav Life Sciences develops Favipiravir for Covid-19 patients

Firm says it has been in talks with at least eight buyers, including a few overseas companies, to supply the anti-retroviral drug

Hyderabad's Raghav Life Sciences develops Favipiravir for Covid-19 patients
Updated On : 05 Jun 2020 | 10:39 PM IST

Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue

Revenues from operations for the quarter under review registered 16.4% growth at Rs 6158.43 crore as compared to Rs 5324.47 crore in the year ago period

Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
Updated On : 03 Jun 2020 | 8:50 PM IST

Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US

Injectibles account for 60% of crunch; most plants under American regulator's lens the past two months have now received positive outcomes

Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US
Updated On : 19 May 2020 | 12:06 AM IST

Pharma traders protest govt's move to add e-pharmacy links to Aarogya Setu

The organisation today alleged that the NITI Aayog has added links to four e-pharmacy players

Pharma traders protest govt's move to add e-pharmacy links to Aarogya Setu
Updated On : 18 May 2020 | 2:08 AM IST

Indian drug makers gear up to make Gilead's remdesivir for Covid-19 therapy

Domestic players will be free to price it; Dutch firm Mylan also to make the drug in India; no royalty for Gilead as yet

Indian drug makers gear up to make Gilead's remdesivir for Covid-19 therapy
Updated On : 14 May 2020 | 9:19 AM IST

Price drives Indian pharmaceutical market growth to five-year high in FY20

Ipca's Zerodol brand and its multiple variants used in treating pain and inflammation are an example of how this trend is playing out

Price drives Indian pharmaceutical market growth to five-year high in FY20
Updated On : 11 May 2020 | 11:05 PM IST

Industry in Ahmedabad face first day jitters of complete lockdown

The first day impact has been more on the pharma especially in the wake of 26 workers at Cadila Pharmaceuticals Ltd.'s facility in Ahmedabad testing positive for COVID-19

Industry in Ahmedabad face first day jitters of complete lockdown
Updated On : 07 May 2020 | 9:06 PM IST

Letter to BS: Pharma industry, pharmacists also deserve appreciation

India has the potential to develop an antidote to Covid-19

Letter to BS: Pharma industry, pharmacists also deserve appreciation
Updated On : 05 May 2020 | 11:28 PM IST

Markets at inflexion point; analysts bullish on consumer, telecom, pharma

The recovery seen in the markets from their March 2020 lows has been quite sharp, with the S&P BSE Sensex and the Nifty50 indices gaining 27.61 per cent and 27.18 per cent, respectively since then

Markets at inflexion point; analysts bullish on consumer, telecom, pharma
Updated On : 30 Apr 2020 | 11:08 AM IST

Diversified model, US outlook to help Dr Reddy's stock trade better

The company has multiple growth engines given its focus on India/emerging markets and limited competition products in the US

Diversified model, US outlook to help Dr Reddy's stock trade better
Updated On : 29 Apr 2020 | 2:01 AM IST

Pharma traders seek IT rule exemption as retailers pay stockists in cash

They fear scrutiny by tax authorities at a later date, assure that the relaxation will not be misused

Pharma traders seek IT rule exemption as retailers pay stockists in cash
Updated On : 24 Apr 2020 | 11:35 PM IST

Pharma shares rally; Alembic, Sun Pharma, Laurus Labs hit 52-wk highs

Strides Pharma Science, Alkem Laboratories, Ajanta Pharma, Lupin, Ipca Laboratories, Jubilant Life Sciences and FDC were up in the range of 5 per cent to 10 per cent on the BSE

Pharma shares rally; Alembic, Sun Pharma, Laurus Labs hit 52-wk highs
Updated On : 24 Apr 2020 | 1:08 PM IST

Pharma traders oppose Medlife-Uber partnership to deliver medicines

Uber, in a press release, had said that the partnership was aimed at ensuring that essential needs are fulfilled right in the safety of customers' homes

Pharma traders oppose Medlife-Uber partnership to deliver medicines
Updated On : 20 Apr 2020 | 2:17 AM IST

From pharmaceuticals to aviation: The impact of coronavirus crisis

Indian airline operators and airports have been the first and the most adversely affected sector.

From pharmaceuticals to aviation: The impact of coronavirus crisis
Updated On : 18 Apr 2020 | 2:18 AM IST

Covid-19 impact: Pharma players join hands to ensure smooth production

Combined capacity utilisation at all-India level is 60-70% - higher than in most other industries

Covid-19 impact: Pharma players join hands to ensure smooth production
Updated On : 12 Apr 2020 | 11:17 PM IST